Telix Pharmaceuticals | TLX - Trade Debtors



Telix Pharmaceuticals reported AUD158.99M in Trade Debtors for its fiscal semester ending in December of 2024.


Trade Debtors Change Date
Cochlear AUD 513.7M 11.7M Dec/2024
CSL USD 3.61B 585M Dec/2024
Integral Diagnostics AUD 24.82M 10.78M Jun/2024
Mayne Pharma AUD 193.22M 5.64M Jun/2024
Medical Developments International AUD 7.81M 743K Dec/2024
Mesoblast 3.4M 600K Jun/2024
Neuren Pharmaceuticals AUD 175.72M 160.85M Dec/2024
Pacific Edge NZD 4.97M 173K Mar/2025
Paradigm Biopharmaceuticals AUD 6.37M 1.29M Dec/2024
Polynovo AUD 20.72M 5.22M Jun/2024
PYC Therapeutics AUD 12.27M 5.73M Dec/2024
Ramsay Health Care AUD 2.39B 135.7M Dec/2024
ResMed USD 990.67M 16.1M Jun/2025
Sonic Healthcare AUD 1.39B 23.76M Dec/2024